Dr. Solomon Zimm, MD, FACP
What this data tells you about Dr. Zimm
Dr. Solomon Zimm is a hematology specialist in Merritt Island, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Zimm performed 154,995 Medicare services across 2,565 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zimm received a total of $235 from 8 pharmaceutical and/or device companies across 9 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zimm is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 50524 | Clear | January 31, 2027 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 32,250 | $1 | $3 |
| Iron infusion (Feraheme) | 23,970 | $0 | $3 |
| Anti-nausea injection (fosaprepitant) | 16,800 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 15,000 | $43 | $107 |
| Epoetin alfa injection (Retacrit) for anemia | 12,482 | $6 | $22 |
| Filgrastim injection (Zarxio) for white blood cells | 12,480 | $0 | $2 |
| Iron sucrose injection (Venofer) | 12,300 | $0 | $1 |
| Tocilizumab injection (Actemra) | 8,560 | $5 | $11 |
| Denosumab injection (Prolia/Xgeva) | 7,320 | $18 | $45 |
| Immune globulin infusion (Gammagard) | 2,450 | $36 | $91 |
| Dexamethasone injection (steroid) | 2,272 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,690 | $1 | $28 |
| Office visit, established patient (20-29 min) | 975 | $64 | $180 |
| Office visit, established patient (30-39 min) | 864 | $93 | $255 |
| Drug injection, under skin or into muscle | 762 | $10 | $42 |
| Anti-nausea injection (ondansetron/Zofran) | 580 | $0 | $1 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 467 | $22 | $57 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 432 | $87 | $334 |
| Administration of chemotherapy into vein, 1 hour or less | 406 | $95 | $257 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 386 | $47 | $132 |
| Injection of additional new drug or substance into vein | 330 | $12 | $36 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 238 | $54 | $143 |
| Injection, diphenhydramine hcl, up to 50 mg | 207 | $1 | $3 |
| Administration of chemotherapy into vein, each additional hour | 173 | $21 | $56 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 138 | $25 | $66 |
| Infusion, normal saline solution , 1000 cc | 119 | $2 | $6 |
| Administration of additional new drug or substance into vein, 1 hour or less | 110 | $49 | $126 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 104 | $16 | $40 |
| Irrigation of implanted venous access drug delivery device | 103 | $18 | $50 |
| Injection, zoledronic acid, 1 mg | 101 | $6 | $35 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 95 | $1 | $5 |
| Red blood cells, leukocytes reduced, each unit | 87 | $49 | $564 |
| Infusion into a vein for hydration, 31-60 minutes | 81 | $21 | $95 |
| Transfusion of blood or blood products | 79 | $30 | $76 |
| Administration of additional new drug or substance into vein using push technique | 74 | $42 | $109 |
| Hospital follow-up visit, moderate complexity | 72 | $61 | $158 |
| Collection of blood sample from implanted device | 69 | $20 | $52 |
| Drawing of blood for a medical problem | 56 | $65 | $189 |
| New patient office visit (45-59 min) | 50 | $114 | $335 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 47 | $4 | $12 |
| Infusion into a vein for hydration, each additional hour | 43 | $8 | $25 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 41 | $244 | $689 |
| Application of on-body injector for under skin injection | 36 | $14 | $37 |
| Injection of drug or substance into vein | 29 | $28 | $90 |
| Office visit, established patient, complex (40-54 min) | 27 | $130 | $358 |
| Initial hospital admission, moderate complexity | 14 | $81 | $265 |
| Initial hospital admission, high complexity | 13 | $127 | $351 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 13 | $162 | $450 |
Industry Payment Transparency
Open Payments through 2022 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2022)
Associated products mentioned in payments ›
The majority of payments (50%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
2.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2022 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Zimm is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Zimm experienced with iron infusion (injectafer)?
Does Dr. Zimm receive payments from pharmaceutical companies?
How do Dr. Zimm's costs compare to other hematologists in Merritt Island?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology